MIRA INFORM REPORT

 

 

Report Date :

22.04.2014

 

IDENTIFICATION DETAILS

 

Name :

SALIUS PHARMA PRIVATE LIMITED

 

 

Registered Office :

Shiv Chamber Office No. 209, Flat No.21, Sector-11, CBD Belapur, Navi Mumbai- 400614, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

05.11.2011

 

 

Com. Reg. No.:

11-223680

 

 

Capital Investment / Paid-up Capital :

Rs. 0.787 Million

 

 

CIN No.:

[Company Identification No.]

U24233MH2011PTC223680

 

 

Legal Form :

Private Limited Liability Company.

 

 

Line of Business :

Manufacturing, trading, marketing and export of wide range of pharmaceutical formulations, APIs, Nutraceuticals and surgical and Herbal products.

 

 

No. of Employees :

30 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 6000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track.

 

Profitability of the company seems to be low during 2013.

 

However, Trade relations are fair. Business is active. Payment are reported to be slow but correct.

 

The company can be considered for business dealing with some cautions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit for the fiscal third quarter ended September 2013 narrowed to $4.2 billion or 0.9 % of the gross domestic product from $31.9 billion or 6.5 % of GDP a year earlier, thanks to a pick-up in exports and moderation in gold imports. Manufacturing activity and new orders in India showed their strongest growth in a year in February. The news comes as a relief after data showed Asia’s third largest economy grew by a slower-than-expected 4.7 % annually in the three months through December. The HSBC Manufacturing Purchasing Managers’ Index which gauges the business activity of India’s factories but not its’ utilities, rose to 52.5 in February, its highest in a year from 51.4 in January. Overall new orders for factory goods which rose to a one-year high of 54.9 contributed to the surge. China has emerged as India’s biggest trading partner in the current financial year replacing the United Arab Emirates and pushing it to the third spot. India-China trade has reached $49.5 billion with a 8.7 % share in India’s total trade. The US comes second at $46 billion with 8.1 % share during the first nine months of the current financial year.

 

The Reserve Bank of India has granted an additional nine months to the public to exchange currency notes printed before 2005 including Rs 500 and Rs 1,000 denominations, pushing the deadline to January 1, 2015. A day before dates for the Lok Sabha polls were announced, the government decided to hike interest rates on fixed deposit schemes offered by post offices up to 0.2 per cent. The new rates will be effective April, 1. The Supreme Court will resume hearing on March, 11 Nokia’s appeal against a ruling over transferring ownership of its local mobile phones plant which is the subject of a tax dispute to Microsoft Corp.

 

In the last days of the current Government, another scam has surfaced. The defence ministry has ordered a probe into Hindustan Aeronautics Limited’s contracts from Britain’s Rolls-Royce Holdings worth at least $ 1.2 billion. The Central Bureau of Investigation will look into allegations that over $80 million was paid in kickbacks in a deal signed in 2011. India has asked Boeing Co. to find a solution for problems with state-owned Air India’s 787 Dreamliners. The aircraft has experienced a series of malfunctions since its debut in 2011.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY

 

Name :

Mr. Ashish

Designation :

Accountant

Contact No.:

91-22-41237868

Date :

04.03.2014

 


 

LOCATIONS

 

Registered Office /Head Office:

Shiv Chamber Office No. 209, Flat No.21, Sector-11, CBD Belapur, Navi Mumbai- 400614, Maharashtra, India

Tel. No.:

91-22-41237868

Fax No.:

91-22-27566752

E-Mail :

akpatrain@yahoo.com

Website

www.saliuspharma.com

 

 

Manufacturing Facility:

Across India and Canada

 

DIRECTORS

 

As on: 28.09.2013

 

Name :

Mr. Rupesh Kumar Gupta

Designation :

Director

Address :

Vil. Lakhanaura, Po. Kishun Pura, P.S. Basant Pursiwan- 841416, Bihar India 

Date of Birth/Age :

12.03.1980

Date of Appointment :

05.11.2011

DIN No.:

03537162

 

 

Name :

Mr. Abani Kanta Nrusingha Patra

Designation :

Director

Address :

207, Swarna Mayee, Berhampur, Ganjam-760001, Orissa, India

Date of Birth/Age :

08.08.1967

Date of Appointment :

05.11.2011

DIN No.:

02149787

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2008PTC183503

CURACION PHARMA PRIVATE LIMITED

Director

24/06/2008

24/06/2008

-

Active

NO

2

U51397MH2010PTC199744

SURLAMER EXPORT PRIVATE LIMITED

Director

05/02/2010

05/02/2010

23/06/2012

Active

NO

3

U24233MH2011PTC223680

SALIUS PHARMA PRIVATE LIMITED

Director

05/11/2011

05/11/2011

-

Active

NO

 

 

Name :

Mr. Rajdev Gulia

Designation :

Director

Address :

7717 146A  Street, Surrey BC V3S, Canada

Date of Birth/Age :

29.11.1980

Date of Appointment :

18.03.2013

DIN No.:

06530276

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24233MH2011PTC223680

SALIUS PHARMA PRIVATE LIMITED

Director

18/03/2013

18/03/2013

-

Active

NO

2

U72900MH2013PTC249209

SALIUS INFOTECH PRIVATE LIMITED

Director

14/10/2013

14/10/2013

-

Active

NO

 

 

Name :

Mr. Harjeet Samra

Designation :

Director

Address :

6185, 138 Street surrey BC V3X 1E8, Canada

Date of Birth/Age :

15.01.1982

Date of Appointment :

18.03.2013

DIN No.:

06530278

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24233MH2011PTC223680

SALIUS PHARMA PRIVATE LIMITED

Director

18/03/2013

18/03/2013

-

Active

NO

2

U72900MH2013PTC249209

SALIUS INFOTECH PRIVATE LIMITED

Director

14/10/2013

14/10/2013

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Ashish

Designation :

Accountant

 

 

MAJOR SHAREHOLDERS

 

As on: 23.09.2013

 

Names of Shareholders

 

No. of Shares

 Abani Kanta Nrusingha Patra

 

46550

Rupesh Kumar Gupta

 

1000

Arti Abani Kanta Patra

 

14450

Saliys Pharma Inc , Canada

 

16707

Total

 

78707

 

 

 

 

As on: 02.12.2013

 

List of Allottee

 

No. of Shares

Salius Pharma INC, Canada

 

17655

Total

 

17655

 

 

Equity Share Break up (Percentage of Total Equity)

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

21.00

Directors or relatives of Directors

79.00

Total

100.00

 


 

BUSINESS DETAILS

 

Line of Business :

Manufacturing, trading, marketing and export of wide range of pharmaceutical formulations, APIs, Nutraceuticals and surgical and Herbal products.

 

 

Terms :

 

Selling :

Cheque

 

 

Purchasing :

Cheque

 

GENERAL INFORMATION

 

Suppliers :

·         DM. Pharma

 

 

Customers :

·         Retailers, End Users,

·         Ysagar Distributors

 

 

No. of Employees :

30 (Approximately)

 

 

Bankers :

Bank of India, Nehrul, Mumbai.

 

Banking Relations :

---

 

 

Auditors :

 

Name :

SPP Associates

Chartered Accountant

Address :

21,Akhurath Chs.Ltd,Plot No 11, Sector 14, Sanpada, Navi Mumbai- 400705, Maharashtra, India

Tel No:

91-22-2781 2000

Email :

susant@sppassociates.com

PAN No.:

AAPFS6872D

 


 

CAPITAL STRUCTURE

 

As on: 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.10/- each

Rs.1.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

78707

Equity Shares

Rs.10/- each

Rs.0.787 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

0.787

0.100

(b) Reserves & Surplus

 

0.724

(0.217)

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.080

Total Shareholders’ Funds (1) + (2)

 

1.511

(0.037)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.203

0.218

(b) Deferred tax liabilities (Net)

 

0.006

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

0.209

0.218

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

0.026

0.000

(c) Other current liabilities

 

0.050

0.010

(d) Short-term provisions

 

0.000

0.000

Total Current Liabilities (4)

 

0.076

0.010

 

 

 

 

TOTAL

 

1.796

0.191

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

0.177     

0.107

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.019

0.024

Total Non-Current Assets

 

0.196

0.131

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

0.297

0.000

(c) Trade receivables

 

0.189

0.000

(d) Cash and cash equivalents

 

0.984

0.060

(e) Short-term loans and advances

 

0.130

0.000

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

1.600

0.060

 

 

 

 

TOTAL

 

1.796

0.191

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

 

2.551

0.000

 

 

Other Income

 

0.008

0.000

 

 

TOTAL                                     (A)

 

2.559

0.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

 

0.851

0.000

 

 

Employees benefits expense

 

0.670

0.040

 

 

Other expenses

 

0.960

0.164

 

 

TOTAL                                     (B)

 

2.481

0.204

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

0.078

(0.204)

 

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

0.003

0.001

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

0.075

(0.205)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

0.031

0.012

 

 

 

 

 

 

PROFIT/LOSS BEFORE TAX (E-F)              (G)

 

0.044

(0.217)

 

 

 

 

 

Less

TAX                                                                  (H)

 

0.021

0.000

 

 

 

 

 

 

PROFIT / LOSS AFTER TAX (G-H)                    (I)

 

0.023

(0.217)

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

2.17

2.13

 

 

Particulars

 

 

 

31.03.2013

Sales Turnover (Approximately)

 

 

9.000

 

Expected Sales (2013-14) : Rs.

 

The above information has been parted by  Mr. Ashish

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2013

31.03.2012

PAT / Total Income

(%)

 

0.90

0.000

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

1.72

0.000

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

2.45

(113.61)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.03

5.86

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

 

0.13

(5.89)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

21.05

6.00

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

0.100

0.787

Reserves & Surplus

(0.217)

0.724

Net worth

(0.117)

1.511

 

 

 

long-term borrowings

0.218

0.203

Short term borrowings

0.000

0.000

Total borrowings

0.218

0.203

Debt/Equity ratio

(1.863)

0.134

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

Sales

0.000

2.551

Profit

(0.217)

0.023

 

0.00%

0.90%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

No

12]

Profitability for last Two years

No

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

No

16]

Details of sister concerns

No

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

 

OPERATION:

 

The company has incorporated on 05 November 2011 as manufacturer and trader of pgarma product total turnover of the company for the year 2012-2013 is Rs. 2.051 Millions including the commission received.

 

Unsecured Loan

 

Particular

As on

31.03.2013

As on

31.03.2012

Long term borrowing

 

 

 

 

 

loan from director and relatives

0.203

0.218

Total

0.203

0.218

 

Note:

The Unsecured Loans were taken from the Directors or their relatives. There is no agreement for the loans taken and no term of payment is specified for the loans. On the basis of the declarations received from the loanees as on the above loans are in the nature of long term loan and not repayable in the next one year.

 

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.33

UK Pound

1

Rs.101.40

Euro

1

Rs.83.38

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

YOG

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.